Stock Showing Surging Activity: Heat Biologics,

Stock Showing Surging Activity: Heat Biologics, Inc. (NASDAQ:HTBX)
By Alvin Buchanan -
December 5, 2016


Heat Biologics, Inc. (NASDAQ:HTBX) belonging to the Medical sector has surged 20.39% and closed its last trading session at $1.24.

The company reported its EPS on 11/11/2016. Currently, the stock has a 1 Year Price Target of $4.5.

The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.

Heat Biologics, Inc. on 11/11/2016 reported its EPS as $-0.08 with the analysts projecting the EPS of the stock as $-0.15. The company beat the analyst EPS Estimate with the difference of $0.07. This shows a surprise factor of 46.7%.

Many analysts have provided their estimated foresights on Heat Biologics, Inc. Earnings, with 2 analysts believing the company would generate an Average Estimate of $-0.1. Whereas they predicted High and Low Earnings Estimate as $-0.07 and $-0.12 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.78.

The Company got Initiated by ROTH Capital on 20-Jun-16 to Buy.

Insider Trades for Heat Biologics, Inc. show that the latest trade was made on 22 Mar 2016 where Kharitonov Michael, the Director completed a transaction type “Buy” in which 900000 shares were traded at a price of $0.75.



2 analysts projected Price Targets for Heat Biologics, Inc.. The analysts believe that the company stock price could grow as high as $7. The Low Price target projection by analysts is $2 and the Mean Price Target is $4.5.

Heat Biologics, Inc. (NASDAQ:HTBX) has the market capitalization of $29.6 Million. The company rocked its 52-Week High of $4.71 on Jan 6, 2016 and touched its 52-Week Low of $0.4 on May 13, 2016. The stock has Return on Assets (ROA) of -140.5 percent. Return on Equity (ROE) stands at -316% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of -49.18 Percent. The company has Beta Value of 0.58 and ATR value of 0.41. The Weekly and Monthly Volatility stands at 29.07% and 18.10%.

Company profile:

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company’s products under development include HS-110 for the treatment of non-small cell lung cancer, HS-410 for the bladder cancer treatment, HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics, Inc. is based in Chapel Hill, North Carolina.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!

Alway's searching for winners'